Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial:

Jean-Marc Naccache, MD Prof Stéphane Jouneau, PhD Morgane Didier, MD Raphaël Borie, PhD Marine Cachanado, MSc Prof Arnaud Bourdin, PhD et al.

7 September, 2021

NZ Respiratory Research Review Issue 201

Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model:

Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann and Christoph Lange

2 September, 2021

NZ Respiratory Research Review Issue 199

Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial (DISARM):

Fernando Sergio Leitao Filho, Hiroto Takiguchi, Kentaro Akata, Seung Won Ra, Ji-Yong Moon, Hyun Kuk Kim, Yuji Cho, Kei Yamasaki, Stephen Milne, Julia Yang, Cheng Wei Tony Yang, Xuan Li, Corey Nislow, Stephan F. van Eeden, Tawimas Shaipanich, Stephen Lam, Janice M. Leung, and Don D. Sin

31 August, 2021

NZ Respiratory Research Review Issue 198

Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism:

Ana Jaureguízar, MD David Jiménez, MD, PhD Behnood Bikdeli, MD Gili Kenet, MD Manuel Monreal, MD, PhD

31 August, 2021

NZ Respiratory Research Review Issue 202

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial:

Prof Stephan Rosenkranz, MD Prof Jeremy Feldman, MD Prof Vallerie V McLaughlin, MD Prof Franz Rischard Dr Tobias J Lange, MD Prof R James White, MD et al

20 August, 2021

NZ Respiratory Research Review Issue 195

High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap:

Pei Yee Tiew, MD, PhD Albert Yick Hou Lim, MD Holly R. Keir, BSc Alison J. Dicker, PhD Micheál Mac Aogáin, PhD Sze Lei Pang, PhD Teck Boon Low, MD Tidi Maharani Hassan, MD Mau Ern Poh, MD Huiying Xu, MD Thun How Ong, MD Mariko Siyue Koh, MD John Arputhan Abisheganaden, MD Augustine Tee, MD Fook Tim Chew, PhD James D. Chalmers, MD, PhD Sanjay H. Chotirmall, MD, PhD

5 August, 2021

NZ Respiratory Research Review Issue 198

Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children:

Robert J. Blount, Ha Phan, Trang Trinh, Hai Dang, Cindy Merrifield, Michael Zavala, Joseph Zabner, Alejandro P. Comellas, Emma M. Stapleton, Mark R. Segal, John Balmes, Nguyen Viet Nhung, and Payam Nahid

3 August, 2021

NZ Respiratory Research Review Issue 199

Development and validation of a model for diagnosis of obstructive sleep apnoea in primary care:

Julia L. Chapman,Camilla M. Hoyos,Roo Killick,Kate Sutherland,Peter A. Cistulli,Nick Zwar,Brendon J. Yee,Guy Marks,Ronald R. Grunstein,Keith K. H. Wong,The Sydney OSA-GP study Investigators

2 August, 2021

NZ Respiratory Research Review Issue 197

Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population-based nested case–control study:

Lianne Parkin,Sheila Williams,Katrina Sharples,David Barson,Simon Horsburgh,Rod Jackson,Billy Wu,Jack Dummer

21 July, 2021

NZ Respiratory Research Review Issue 192

Variations in Processes of Care and Outcomes for Hospitalized General Medicine Patients Treated by Female vs Male Physicians:

Anjali Sergeant, BASc; Sudipta Saha, SM; Saeha Shin, MPH; et al

16 July, 2021

NZ Respiratory Research Review Issue 192